B3GAT1 and cancer: This lower CD57 expression was not due to the increased frequency of immature CD56bright cells in the total NK population as both CD56dim subsets of NK cells (CD56dim CD16+ and CD56dimCD16-) in cancer patients expressed significantly lower levels of CD57 compared to the same subsets in controls (Figure S8).